advertisement

Topcon

GLIA 13

Showing records 1 to 13 | Display all abstracts in GLIA

119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Liu K
GLIA 2024; 72: 1555-1571
121266 MicroRNA-146a-5p protects retinal ganglion cells through reducing neuroinflammation in experimental glaucoma
Zhou H; Yang RK
GLIA 2024; 72: 2115-2141
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Yang Y; Wu Z
GLIA 2024; 72: 1555-1571
121266 MicroRNA-146a-5p protects retinal ganglion cells through reducing neuroinflammation in experimental glaucoma
Li Q
GLIA 2024; 72: 2115-2141
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Sun C
GLIA 2024; 72: 1555-1571
121266 MicroRNA-146a-5p protects retinal ganglion cells through reducing neuroinflammation in experimental glaucoma
Li Z; Wang YC
GLIA 2024; 72: 2115-2141
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Su Y
GLIA 2024; 72: 1555-1571
121266 MicroRNA-146a-5p protects retinal ganglion cells through reducing neuroinflammation in experimental glaucoma
Li SY
GLIA 2024; 72: 2115-2141
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Huang N; Wu H
GLIA 2024; 72: 1555-1571
121266 MicroRNA-146a-5p protects retinal ganglion cells through reducing neuroinflammation in experimental glaucoma
Miao Y
GLIA 2024; 72: 2115-2141
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Yi C
GLIA 2024; 72: 1555-1571
121266 MicroRNA-146a-5p protects retinal ganglion cells through reducing neuroinflammation in experimental glaucoma
Sun XH; Wang Z
GLIA 2024; 72: 2115-2141
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Ye J; Xiao L; Niu J; Niu J
GLIA 2024; 72: 1555-1571

Issue 25-1

Change Issue


advertisement

Topcon